Covidien and Welch Allyn have agreed a collaboration to create a vital signs monitoring system that acts as three devices in one—offering spot-check, monitoring and triage.
Covidien’s Nellcor OxiMax platform with SatSeconds technology is to be integrated into the Welch Allyn Connex Vital Signs Monitor (VSM), creating a suite of patient monitoring solutions for use on the general care floor in hospitals, surgery centers and other ambulatory care offices.
The same OxiMax technology is featured in the Nellcor OxiMax N-600x pulse oximeter, and delivers accurate, reliable readings even during low perfusion and signal interference.
The OxiMax platform monitors oxygen saturation (SpO2) levels — a critical measure of respiratory function – while the SatSeconds feature alerts healthcare providers when patient saturation drops below the established SpO2 threshold.
“The ability of our SatSeconds feature to help minimise clinically insignificant desaturation alarms is an important benefit in the healthcare setting,” said Robert J. White, Vice President, General Manager, Patient Monitoring, Respiratory and Monitoring Solutions, Covidien.
“We are delighted that this collaboration expands the availability of OxiMax technology to a greater number of caregivers and the patients they serve.”
The Connex VSM (pictured) provides information such as heart rate, blood pressure, temperature and pulse oximetry; manual parameters such as respiration, height, weight and pain level; and modifiers such as body position and O2 therapy details.
“The integration of the SatSeconds alert feature into our Connex VSM means we can offer the clinical benefits of this technology to our customers, and continue to deliver comprehensive monitoring solutions,” added Scott Gucciardi, Senior Vice President, Welch Allyn.